Please login to the form below
ICU Medical
This page shows the latest ICU Medical news and features for those working in and with pharma, biotech and healthcare.
Pfizer to shut down two UK manufacturing sites
Pfizer has already sold off Hospira's infusion therapy business unit, bringing in $600m in cash and $400m in stock from buyer ICU Medical as it looks to focus on pharmaceuticals.
Latest news
-
Pfizer to sell off Hospira's infusions business - and its New York HQ
The business unit - which produces pumps, infusion solutions and other devices - is being bought by ICU Medical, a specialist in infusion therapy. ... The ICU Medical deal is expected to close in the first quarter of 2017, said the two companies in a
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
$223m royalties. $142m. 1.6. Cardiovascular 2016. China Medical System. Plendil China. ... 1, 120. Hospira / Pfizer (US). ICU Medical (US). Asset Acquisition.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
